Serge Lepage

4.6k total citations · 2 hit papers
50 papers, 2.0k citations indexed

About

Serge Lepage is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Serge Lepage has authored 50 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Serge Lepage's work include Heart Failure Treatment and Management (17 papers), Cardiovascular Function and Risk Factors (8 papers) and Acute Myocardial Infarction Research (6 papers). Serge Lepage is often cited by papers focused on Heart Failure Treatment and Management (17 papers), Cardiovascular Function and Risk Factors (8 papers) and Acute Myocardial Infarction Research (6 papers). Serge Lepage collaborates with scholars based in Canada, United States and France. Serge Lepage's co-authors include Eugene Braunwald, Marc A. Pfeffer, Nader Rifai, Paul M. Ridker, Frank M. Sacks, R. Grant Ingram, Kwan‐Leung Chan, Christopher Thompson, Randolph P. Martin and Anthony Sanfilippo and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of Geophysical Research Atmospheres.

In The Last Decade

Serge Lepage

47 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial Infarction

2000 777 citations Serge Lepage, Eugene Braunwald et al. profile →
Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure

2023 81 citations Robert J. Mentz, Jonathan H. Ward et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Serge Lepage Canada	19	1.2k	365	264	258	236	50	2.0k
Joseph B Muhlestein United States	23	1.0k 0.9×	491 1.3×	585 2.2×	230 0.9×	133 0.6×	69	2.5k
Achille Venco Italy	32	1.7k 1.5×	443 1.2×	611 2.3×	208 0.8×	193 0.8×	122	3.3k
Sune Pedersen Denmark	25	866 0.7×	273 0.7×	248 0.9×	133 0.5×	259 1.1×	78	1.6k
Hee Tae Yu South Korea	34	2.9k 2.5×	562 1.5×	251 1.0×	341 1.3×	202 0.9×	233	4.0k
Ercan Varol Türkiye	26	1.1k 0.9×	187 0.5×	377 1.4×	80 0.3×	142 0.6×	107	1.9k
Hongwei Li China	20	737 0.6×	241 0.7×	369 1.4×	75 0.3×	148 0.6×	135	1.6k
Birgit Vogel United States	24	1.3k 1.1×	215 0.6×	878 3.3×	139 0.5×	266 1.1×	119	2.6k
Jidong Sung South Korea	23	1.1k 0.9×	197 0.5×	475 1.8×	76 0.3×	329 1.4×	120	2.1k
Luca Zanoli Italy	23	577 0.5×	237 0.6×	329 1.2×	136 0.5×	117 0.5×	90	1.7k
Ho‐Joong Youn South Korea	23	1.4k 1.2×	177 0.5×	497 1.9×	94 0.4×	572 2.4×	282	2.2k

Countries citing papers authored by Serge Lepage

Since Specialization

Citations

This map shows the geographic impact of Serge Lepage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Lepage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Lepage more than expected).

Fields of papers citing papers by Serge Lepage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serge Lepage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Lepage. The network helps show where Serge Lepage may publish in the future.

Co-authorship network of co-authors of Serge Lepage

This figure shows the co-authorship network connecting the top 25 collaborators of Serge Lepage. A scholar is included among the top collaborators of Serge Lepage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge Lepage. Serge Lepage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gunn, Alexander, Derek D. Cyr, Adrian F. Hernandez, et al.. (2025). Sacubitril/Valsartan Versus Valsartan Initiation in Patients Naïve to Renin–angiotensin System Inhibitors: Insights from PARAGLIDE-HF. European Journal of Heart Failure. 27(8). 1418–1425. 1 indexed citations

Morrow, David A., Eric J. Velazquez, Akshay S. Desai, et al.. (2024). Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure. Journal of the American College of Cardiology. 83(12). 1123–1132. 10 indexed citations

Fudim, Marat, Derek D. Cyr, Jonathan H. Ward, et al.. (2024). Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF Trial. Journal of Cardiac Failure. 30(12). 1568–1577. 5 indexed citations

Morrow, David A., Eric J. Velazquez, Akshay S. Desai, et al.. (2024). Efficacy And Safety Of Sacubitril/valsartan In Patients Hospitalized With Heart Failure: A Prespecified, Pooled Individual Patient-level Analysis Of PIONEER-HF And PARAGLIDE-HF. Journal of Cardiac Failure. 30(1). 312–313.

Ducharme, Anique, Shelley Zieroth, Kim Anderson, et al.. (2023). Canadian Cardiovascular Society-Canadian Heart Failure Society Focused Clinical Practice Update of Patients With Differing Heart Failure Phenotypes. Canadian Journal of Cardiology. 39(8). 1030–1040. 8 indexed citations

Mentz, Robert J., Jonathan H. Ward, Adrian F. Hernandez, et al.. (2023). Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event. Journal of Cardiac Failure. 29(6). 922–930. 18 indexed citations

Mentz, Robert J., Jonathan H. Ward, Adrian F. Hernandez, et al.. (2023). Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure. Journal of the American College of Cardiology. 82(1). 1–12. 81 indexed citations breakdown →

Weinstein, Jordan, Louis Girard, Serge Lepage, Robert S. McKelvie, & Karthik Tennankore. (2021). Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors. Canadian Medical Association Journal. 193(48). E1836–E1841. 14 indexed citations

d’Entremont, Marc-André, Thao Huynh, Étienne Croteau, et al.. (2021). The feasibility, reliability, and incremental value of two-dimensional speckle-tracking for the detection of significant coronary stenosis after treadmill stress echocardiography. Cardiovascular Ultrasound. 19(1). 27–27. 5 indexed citations

10.

Lepage, Serge, et al.. (2019). Increased level of high-sensitivity cardiac Troponin T in a geriatric population is determined by comorbidities compared to age. IJC Heart & Vasculature. 22. 187–191. 24 indexed citations

11.

Couture, Étienne, Serge Lepage, Jean‐Bernard Masson, & Benoit Daneault. (2017). Very late transcatheter heart valve thrombosis. World Journal of Cardiology. 9(2). 196–196. 4 indexed citations

12.

Feldman, Debbie Ehrmann, Thao Huynh, Nadia Giannetti, et al.. (2013). Access to heart failure care post emergency department visit: Do we meet established benchmarks and does it matter?. American Heart Journal. 165(5). 725–732. 15 indexed citations

13.

Farand, Paul, et al.. (2013). Effect of age and sex on echocardiographic left ventricular diastolic function parameters in patients with preserved ejection fraction and normal valvular function. Cardiology Journal. 20(5). 513–518. 18 indexed citations

14.

Lepage, Serge. (2008). Acute decompensated heart failure. Canadian Journal of Cardiology. 24. 6B–8B. 17 indexed citations

15.

Gervais, André, et al.. (2006). Same-day transfer of patients with unstable angina and non-ST segment elevation myocardial infarction back to their referring hospital after angioplasty. Canadian Journal of Cardiology. 22(5). 405–409. 10 indexed citations

16.

Carrier, Julie, et al.. (2004). A Six-Year Experience with the Omnicarbon Valve in North American Patients. Journal of Cardiac Surgery. 19(5). 432–437. 1 indexed citations

17.

Rakowski, Harry, Christopher P. Appleton, Kwan‐Leung Chan, et al.. (1996). Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography. Journal of the American Society of Echocardiography. 9(5). 736–760. 484 indexed citations

18.

Davies, Richard F., W. Peter Klinke, Claude Nadeau, et al.. (1995). Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Journal of the American College of Cardiology. 25(3). 619–625. 82 indexed citations

19.

Davies, Richard F., Wolfgang Linden, W. Peter Klinke, et al.. (1993). Relative importance of psychologic traits and severity of ischemia in causing angina during treadmill exercise. Journal of the American College of Cardiology. 21(2). 331–336. 29 indexed citations

20.

Lepage, Serge, et al.. (1993). Massive Hydrothorax Compacting Peritoneal Dialysis. Clinical Nuclear Medicine. 18(6). 498–501. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact